Posted inMarket Pulmovant Set to Reveal Phase 2 Mosliciguat Study Findings on Tuesday Pulmovant is preparing to unveil key Phase 2 clinical trial data for mosliciguat on Tuesday, offering new insights for respiratory medicine. Posted by Prasenjit Bhowmik October 26, 2026
